Position in IQV
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$532,900
+$51,807 QoQ
Shares Held
2,758
-2.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#628
of 1,082 holders
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in IQV Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Raleigh Capital Management Inc. holds $764,974 across 5 Diagnostics & Research names. IQV ranks #1 (69.7% of the industry book) .
All Filings in IQV
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $532,900 | 2,758 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $481,093 | 2,821 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $658,648 | 2,922 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $607,997 | 3,201 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $527,926 | 3,350 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $318,397 | 1,806 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $73,494 | 374 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $400,005 | 1,688 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $279,100 | 1,320 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $328,757 | 1,300 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $267,706 | 1,157 | Shares | Sole | 2024-02-21 | |
| 2023-09-30 | $217,802 | 1,107 | Shares | Sole | 2023-12-08 | |
| 2023-06-30 | $242,526 | 1,079 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $192,127 | 966 | Shares | Sole | 2023-05-22 | |
| 2022-12-31 | $3,483 | 17 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $2,898 | 16 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $3,471 | 16 | Shares | Sole | 2022-08-30 | |
| 2021-12-31 | $1,128 | 4 | Shares | Sole | 2022-02-16 | |
| No filing history on record for this holder in this stock. | ||||||